Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2012
08/02/2012US20120196917 Antidepressant Oral Liquid Compositions
08/02/2012US20120196906 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors
08/02/2012US20120196905 Synthetic compounds and methods to decrease nicotine self-administration
08/02/2012US20120196904 Nitrocatechol derivatives as comt inhibitors
08/02/2012US20120196903 2-aminooxazolines as taar1 ligands
08/02/2012US20120196902 Sulfoximines as kinase inhibitors
08/02/2012US20120196901 Tertiary amide orexin receptor antagonists
08/02/2012US20120196899 Methods and products for treating inflammation
08/02/2012US20120196898 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
08/02/2012US20120196895 Novel forms of eperisone
08/02/2012US20120196892 Novel caspase-2 inhibitors
08/02/2012US20120196890 4-substituted azaadamantane derivatives and methods of use thereof
08/02/2012US20120196888 Process for preparing oxymorphone, naltrexone, and buprenorphine
08/02/2012US20120196884 Urea substituted sulphonamide derivatives
08/02/2012US20120196883 Selective calcium channel antagonists
08/02/2012US20120196877 Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions
08/02/2012US20120196872 New 5-alkynyl-pyridines
08/02/2012US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/02/2012US20120196866 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/02/2012US20120196865 Acyl Guanidine Derivatives Modulating The Hedgehog Protein Signaling Pathway
08/02/2012US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors
08/02/2012US20120196861 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196857 Modulators of Muscarinic Receptors
08/02/2012US20120196856 Aryl aminopyridine pde10 inhibitors
08/02/2012US20120196855 Oxygen linked pyrimidine derivatives
08/02/2012US20120196845 Quinolinone-pyrazolone m1 receptor positive allosteric modulators
08/02/2012US20120196831 COMPOSITION FOR TREATING AND PREVENTING OBESITY INCLUDING HIGH WATER-SOLUBLE 2-HYDROXYPROPYL-betaCYCLODEXTRIN AS EFFECTIVE COMPONENT
08/02/2012US20120196824 Therapeutic agent for cerebral infarction
08/02/2012US20120196819 Animal treatments
08/02/2012US20120196815 Withanolide Isolated from Physalis longifolia and Analogs and Methods of Use Thereof
08/02/2012US20120196812 Pharmaceutical composition, methods for treating and uses thereof
08/02/2012US20120196809 Use of icam-1 for prevention or treatment of neurological diseases
08/02/2012US20120196803 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
08/02/2012US20120196796 Amylin family peptides and methods for making and using them
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
08/02/2012US20120196749 Cyclosporin Derivatives
08/02/2012US20120196301 Use of binding partners for 5-ht5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders
08/02/2012US20120195985 Glycine transporter-1 inhibitors
08/02/2012US20120195984 Diagnosis and treatment of the prodromal schizophrenic state
08/02/2012US20120195981 Micronutrient supplement with calcium, vitamin d or calcium & vitamin d combination for premenstrual syndrome, postpartum depression, depression and panic attacks
08/02/2012US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
08/02/2012US20120195963 Highly purified ethyl epa and other epa derivatives
08/02/2012US20120195959 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin
08/02/2012US20120195955 Sublingual films
08/02/2012US20120195954 Method of Reducing Appetite
08/02/2012US20120195942 Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
08/02/2012US20120195933 Pharmaceutical compositions comprising tasocitinib
08/02/2012US20120195932 Geodate delivery vehicles
08/02/2012US20120195930 Novel pyridine derivatives
08/02/2012US20120195921 Recombinant t-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
08/02/2012US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid
08/02/2012US20120195881 Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions and their use
08/02/2012US20120195880 Modulation of Synaptic Maintenance
08/02/2012US20120195878 Protocol for the administration of botulinum toxins
08/02/2012US20120195865 Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
08/02/2012US20120195860 Latent neural stem cell population
08/02/2012CA2825906A1 Compounds for the reduction of .beta.-amyloid production
08/02/2012CA2825816A1 Analgesic compounds, methods, and formulations
08/02/2012CA2825810A1 Use of potassium channel blockers to treat cerebral palsy
08/02/2012CA2825142A1 Use of nicotinic acetylcholine receptor alpha 7 activators
08/02/2012CA2824679A1 Pharmaceutical composition comprising pyridone derivatives
08/02/2012CA2824467A1 Pharmaceutical composition comprising pyridone derivatives
08/02/2012CA2823505A1 Sense-improving agent
08/01/2012EP2481757A1 Treatment of multiple sclerosis and/or rheumatoid arthritis
08/01/2012EP2481738A1 Maleic acid salt and crystal thereof
08/01/2012EP2481725A1 Substituted amide compound
08/01/2012EP2481410A1 Nitrocatechol derivates as COMT inhibitors administered with a specific dosage regime
08/01/2012EP2481408A2 New use of glutaminyl cyclase inhibitors
08/01/2012EP2481407A1 Compounds for use in treating cognitive disorders
08/01/2012EP2481406A1 Use of piperphentonamine or salts thereof in manufacture of medicaments for preventing / treating brain diseases
08/01/2012EP2480549A1 Fused imidazo [3, 2 - d]pyrazines as pi3 kinase inhibitors
08/01/2012EP2480536A2 Toll-like receptor modulators and uses thereof
08/01/2012EP2480527A1 Sulfanylamide derivatives, uses thereof and compositions comprising them
08/01/2012EP2480228A1 Use of nicotinic acetylcholine receptor alpha 7 activators
08/01/2012EP2480221A2 Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
08/01/2012EP2480080A1 Pyrido[3,4-b]indoles and methods of use
08/01/2012EP2480078A1 Pyrido[4,3-b]indoles and methods of use
08/01/2012EP2480076A1 Imidothiazole kinase inhibitors
08/01/2012EP2358714B1 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
08/01/2012EP2297166B1 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
08/01/2012EP2252578B1 Conjugates for treating neurodegenerative diseases and disorders
08/01/2012EP2250176B1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
08/01/2012EP2235013B1 Substituted tetrahydroimidazopyridine compounds and the use thereof in pharmaceuticals
08/01/2012EP2197475B1 Use of gip for the treatment of disorders associated with dysfunctional synaptic transmission
08/01/2012EP2193793B1 Nerve cell death inhibitor
08/01/2012EP2155335B1 Pharmaceutical composition, use of the pharmaceutical composition for treating a brain tumor, production process thereof and a kit of parts comprising the pharmaceutical composition
08/01/2012EP2131841B1 Methods for treating acute pain
08/01/2012EP2121630B1 Fast dissociating dopamine 2 receptor antagonists
08/01/2012EP2043625B1 Nfkappab inhibitors to treat pain locally
08/01/2012EP2024363B1 N-oxides of pyridylmethylpiperazine and -piperidine derivatives
08/01/2012EP2016039B1 Terphenyl derivatives for treatment of alzheimer' s disease
08/01/2012EP1915994B1 Cyclic amine derivatives in combination with ppar regulators
08/01/2012EP1871749B1 Selurampanel
08/01/2012EP1848426B1 Tricyclic cytoprotective compounds
08/01/2012EP1846415B1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
08/01/2012EP1432407B2 Lisinopril compositions having large-particle dcpd
08/01/2012EP1333853B1 Growth factor complex
08/01/2012EP1328653B1 Highly expressible genes
08/01/2012CN1993333B Triazole derivative
1 ... 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... 1833